Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease

Neurotoxicity Research

Volumn 5, Issue 6, 2003, Pages 385-397

  Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Activation; Alzheimer disease; Blood flow; Brain; Cytochrome oxidase; Energy; Glucose; Metabolism; Mitochondria; mRNA; Neurofibrillary tangles; Oxidative phosphorylation; Positron emission tomography; Senile plaques; Synapse

Indexed keywords

ALZHEIMER DISEASE; BRAIN; BRAIN LEVEL; DIAGNOSTIC IMAGING; DISEASE COURSE; HUMAN; METABOLISM; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNAPSE;

ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; OXIDATIVE PHOSPHORYLATION; SYNAPSES;

EID: 1342269756     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033167     Document Type: Article

References (95)

1. Akiyama H, S Barger, S Barnum, B Bradt, J Bauer, GM Cole, NR Cooper, P Eikelenboom, M Emmerling, BL Fiebich, CE Finch, S Frautschy, WS Griffin, H Hampel, M Hull, G Landreth, L Lue, R Mrak, IR Mackenzie, PL McGeer, MK O'Banion, J Pachter, G Pasinetti, C Plata-Salaman, J Rogers, R Rydel, Y Shen, W Streit, R Strohmeyer, I Tooyoma, FL Van Muiswinkel, R Weerhuis, D Walker, S Webster, B Wegrzyniak, G Wenk and T Wyss-Coray (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421.
2. Attardi G and G Schatz (1988) Biogenesis of mitochondria. Annu. Rev. Cell Biol. 4, 289-333.
3. Barger SW and AS Basile (2001) Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 76, 846-854.
4. Beal MF (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211-223.
5. Bookheimer SY, MH Strojwas, MS Cohen, AM Saunders, MA Pericak-Vance, JC Mazziotta, and GW Small (2000) Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343, 450-456.
6. Braak H and E Braak (1998) Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 53, 127-140.
7. Brodal A (1981) Neurological Anatomy in Relation to Clinical Medicine, 3rd Ed. (Oxford University Press, Oxford).
8. Burggren AC, GW Small, FW Sabb and SY Bookheimer (2002) Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am. J. Geriatr. Psychiatry 10, 44-51.
9. Calingasan NY, K Uchida and GE Gibson (1999) Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72, 751-756.
10. Chandrasekaran K, J Stoll, DR Brady and SI Rapoport (1992) Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex in the monkey brain: Correlation with specific neuronal pathways. Brain Res. 579, 333-336.
11. Chandrasekaran K, J Stoll, SI Rapoport and DR Brady (1993) Localization of cytochrome oxidase (COX) activity and COX mRNA in the perirhinal and superior temporal sulci of the monkey brain. Brain Res. 606, 213-219.
12. Chandrasekaran K, T Giordano, DR Brady, J Stoll, LJ Martin and SI Rapoport (1994) Impairment of mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res. Mol. Brain Res. 24(S-1), 336-340.
13. Chandrasekaran K, K Hatanpää, DR Brady and SI Rapoport (1996) Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp. Neurol. 142, 80-88.
14. Chandrasekaran K. K. Hatanpää, SI Rapoport and DR Brady (1997) Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex of Alzheimer disease. Brain Res. Mol. Brain Res. 44, 99-104.
15. Chandrasekaran K, K Hatanpää, DR Brady, J Stoll and SI Rapoport (1998) Downregulation of oxidative phosphorylation in Alzheimer disease: Loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex. Brain Res. 796, 13-19.
16. Chandrasekaran K and SI Rapoport (unpublished observations).
17. Chrzanowska-Lightowlers ZM, T Preiss and RN Lightowlers (1994) Inhibition of mitochondrial protein synthesis promotes increased stability of nuclear-encoded respiratory gene transcripts. J. Biol. Chem. 269, 27322-27328.
18. Davies CA, DMA Mann, PQ Sumpter and PO Yates (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78, 151-164.
19. DeCarli CS, JR Atack, MJ Ball, JA Kaye, CL Grady, P Fewster, KD Pettigrew, SI Rapoport and MB Schapiro (1992) Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegeneration 1, 113-121.
20. DeCarli C, DG Murphy, JA Gillette, JV Haxby, D Teichberg, MB Schapiro and B Horwitz (1994) Lack of age-related differences in temporal lobe volume of very healthy adults. Am. J. Neuroradiol. 15, 689-696.
21. DeKosky ST and SW Scheff (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol. 27, 457-464.
22. Folstein MF, SE Folstein and PR McHugh (1975) Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
23. Fukuyama R, K Hatanpää, SI Rapoport and K Chandrasekaran (1996) Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients. Brain Res. 713, 290-293.
24. Gaines G, C Rossi and G Attardi (1987) Markedly different ATP requirements for rRNA synthesis and mtDNA light strand transcription versus mRNA synthesis in isolated human mitochondria. J. Biol. Chem. 262, 1907-1915.
25. Gelfand R and G Attardi (1981) Synthesis and turnover of mitochondrial ribonucleic acid in HeLa cells: The mature ribosomal and messenger ribonucleic acid species are metabolically unstable. Mol. Cell. Biol. 1, 497-511.
26. Gong Y, L Chang, KL Viola, PN Lacor, MP Lambert, CE Finch, GA Krafft and WL Klein (2003) Alzheimer's disease-affected brain: Presence of oligomeric Abeta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA 100, 10417-10422.
27. Grady CL (2002) Age-related differences in face processing: A meta-analysis of three functional neuroimaging experiments. Can. J. Exp. Psychol. 56, 208-220.
28. Grady CL, B Sonies, J Haxby, J Luxenberg, R Friedland and S Rapoport (1988) Cerebral metabolic asymmetries predict decline in language performance in dementia of the Alzheimer type (DAT). J. Clin. Exp. Neuropsychol. 10, 39.
29. Grady CL, JV Haxby, B Horwitz, J Gillette, JA Salerno, A Gonzalez-Aviles, RE Carson, P Herscovitch, MB Schapiro and SI Rapoport (1993) Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol. Aging 14, 35-44.
30. Greenamyre JT, WF Maragos, RL Albin, JB Penney and AB Young (1988) Glutamate transmission and toxicity in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 12, 421-430.
31. Greene JG and JT Greenamyre (1996) Bioenergetics and glutamate excitotoxicity. Prog. Neurobiol. 48, 613-634.
32. Hake AM and MR Farlow (2001) New concepts in the drug therapy of Alzheimer's disease. Expert Opin. Pharmacother. 2, 1975-1983.
33. Hatanpää K, DR Brady, J Stoll, SI Rapoport and K Chandrasekaran (1996) Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 40, 411-420.
34. Hatanpää K, K Chandrasekaran, D Brady and SI Rapoport (1998) No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Brain Res. Mol. Brain Res. 59, 13-21.
35. Hatanpää K, KR Isaacs, T Shirao, DR Brady and SI Rapoport (1999) Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58, 637-643.
36. Haxby JV, R Duara, CL Grady, NR Cutler and SI Rapoport (1985) Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cereb. Blood Flow Metab. 5, 193-200.
37. Hevner RF and MTT Wong-Riley (1991) Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: Comparison with CO activity and protein. J. Neurosci. 11, 1942-1958.
38. Hevner RF and MTT Wong-Riley (1993) Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J. Neurosci. 13, 1805-1819.
39. +-ATPase. Neurosci. Lett. 138, 188-192.
40. Ibanez V, P Pietrini, GE Alexander, ML Furey, D Teichberg, JC Rajapakse, SI Rapoport, MB Schapiro and B Horwitz (1998) Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50, 1585-1593.
41. Iqbal K, C Alonso Adel, E El-Akkad, CX Gong, N Haque, S Khatoon, I Tsujio and I Grundke-Iqbal (2002) Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration. J. Neural Transm. Suppl. 62, 309-319.
42. Irizarry MC, F Soriano, M McNamara, KJ Page, D Schenk, D Games and BT Hyman (1997) Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053-7059.
43. Katzman R (1976) The prevalence and malignancy of Alzheimer disease: A major killer. Arch. Neurol. 33, 217-218.
44. Kennedy AM, RSJ Frackowiak, SK Newman, PM Bloomfield, J Seaward, P Roques, G Lewington, VJ Cunningham and MN Rossor (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett. 186, 17-20.
45. Kumar A, MB Schapiro, C Grady, JV Haxby, E Wagner, JA Salerno, RP Friedland and SI Rapoport (1991) High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 4, 35-46.
46. Lehninger AL, DL Nelson and MM Cox (1993) Principles of Biochemistry, 2nd Ed., Chapter 15, pp. 446-448; Chapter 20, pp. 669-683 (Worth Press: New York).
47. Lewis DA, MJ Campbell, RD Terry and JH Morrison (1987) Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J. Neurosci. 7, 1799-1808.
48. Liu LI, SI Rapoport and K Chandrasekaran (1999) Regulation of mitochondrial gene expression in differentiated PC12 cells. Ann. NY Acad. Sci. 893, 341-344.
49. Mann DMA, B Marcyniuk, PO Yates, D Neary and JS Snowden (1988) The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol. Appl. Neurobiol. 14, 177-195.
50. Masliah E and E Rockenstein (2000) Genetically altered transgenic models of Alzheimer's disease. J. Neurol. Transm. Suppl. 59, 175-183.
51. Mattson MP, DS Gary, SL Chan, W Duan, SW Barger and AS Basile (2001) Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem. Soc. Symp. 76, 151-162.
52. Mecocci P, U MarGarvey and MF Beal (1994) Oxidative damage to mitochondria DNA is increased in Alzheimer disease. Ann. Neurol. 36, 747-751.
53. Mentis MJ, B Horwitz, CL Grady, GE Alexander, JW VanMeter, JM Maisog, P Pietrini, MB Schapiro and SI Rapoport (1996) Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am. J. Psychiatry 153, 32-40.
54. Mentis MJ, GE Alexander, CL Grady, B Horwitz, J Krasuski, P Pietrini, T Strassburger, H Hampel, MB Schapiro and SI Rapoport (1997) Frequency variation of a pattern-flash visual stimulus during PET differentially activates brain from striate through frontal cortex. Neuroimage 5, 116-128.
55. Mentis MJ, GE Alexander, J Krasuski, P Pietrini, ML Furey, MB Schapiro and SI Rapoport (1988) Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation. Am. J. Psychiatry 155, 785-794.
56. Mentis MJ, T Sunderland, J Lai, C Connolly, J Krasuski, B Levine, J Friz, S Sobti, M Schapiro and SI Rapoport (2001) Muscarinic versus nicotinic modulation of a visual task. A PET study using drug probes. Neuropsychopharmacology 25, 555-564.
57. Micol V, P Fernandez-Silva and G Attardi (1997) Functional analysis of in vivo and in organello footprinting of HeLa cell mitochondrial DNA in relationship to ATP and ethidium bromide effects on transcription. J. Biol. Chem. 272, 18896-18904.
58. Montoya J, T Christianson, D Levens, M Rabinowitz and G Attardi (1982) Identification of initiation sites for heavy-strand and light-strand transcription in human mitochondrial DNA. Proc. Natl. Acad. Sci. USA 79, 7195-7199.
59. Mrak RE and WS Griffin (2001) Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol. Aging 22, 903-908.
60. Nagy Z, MM Esiri, M LeGris and PM Matthews (1999) Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol. (Berl.) 97, 346-354.
61. Parker Jr WD, J Parks, CM Filley and BK Kleinschmidt-DeMasters (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44, 1090-1096.
62. Pellmar TC, DA Schauer and GH Zeman (1990) Time-and dosedependent changes in neuronal activity produced by X radiation in brain slices. Radiation Res. 122, 209-214.
63. Peterson E (2003) Mild Cognitive Impairment: Aging to Alzheimer's Disease (Oxford University Press: New York), p. 269.
64. Pietrini P, GE Alexander, ML Furey, A Dani, MJ Mentis, B Horwitz, M Guazzelli, MB Shapiro and SI Rapoport (2000) Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET. J. Nucl. Med. 41, 575-583.
65. Purdon AD and SI Rapoport (1998) Energy requirements for two aspects of phospholipid metabolism in mammalian brain. Biochem. J. 335, 313-318.
66. Rapoport SI (1990) Integrated phylogeny of the primate brain, with special reference to humans and their diseases. Brain Res. Rev. 15, 267-294.
67. Rapoport SI (1991) Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovasc. Brain Metab. Rev. 3, 297-335.
68. Rapoport SI (1995) Anatomic and functional brain imaging in Alzheimer's disease, In: PTychopharmacology: the Fourth Generation of Progress, Bloom FE and DJ Kupfer, Eds. (Raven: New York), pp. 1401-1415.
69. Rapoport SI (1997) Deux stades, réversible et irréversible, de l'insuffisance fonctionnelle dans le cerveau Alzheimerien, In: De la Neurophysiologie à la Maladie D'Alzheimer: Symposium en Hommage à Yvon Lamour, Y. Christien, Eds. (Solal: Marseille), pp. 165-172.
70. Rapoport SI and CL Grady (1993) Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease. Int. J. Neurosci. 70, 39-56.
71. Rapoport SI, K Hatanpää, DR Brady and K Chandrasekaran (1996) Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease. Neurodegeneration 5, 473-476.
72. Reiman EM, RJ Caselli, LS Yun, K Chen, D Bandy, S Minoshima, SN Thibodeau and D Osbome (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334, 752-758.
73. Reivich M (1974) Blood flow metabolism couple in brain. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 53, 125-140.
74. Rojas-Fernandez CH, M Chen and HL Fernandez (2002) Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease. Pharmacotherapy 22, 1547-1563.
75. Roy CS and CS Sherrington (1890) On the regulation of the blood supply of the brain. J. Physiol. (Lond.) 11, 85-105.
76. Rutten BP, O Wirths, WD Van de Berg, SF Lichtenthaler, J Vehoff, HW Steinbusch, H Korr, K Beyreuther, G Multhaup, TA Bayer and C Schmitz (2003) No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment. Neurobiol. Dis. 12, 110-120.
77. Sato M, T Kawarabayashi, M Shoji, T Kobayashi, N Tada, E Matsubara and S Hirai (1997) Neurodegeneration and gliosis in transgenic mice overexpressing a carboxy-terminal fragment of Alzheimer amyloid-beta protein precursor. Dement. Geriatr. Cogn. Disord. 8, 296-307.
78. Scheff SW, ST DeKosky and DA Price (1990) Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging 11, 29-37.
79. Scheff SW, DL Sparks and DA Price (1996) Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia 7, 226-232.
80. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
81. Sheetz MP, ER Steuer and TA Schroer (1989) The mechanism and regulation of fast axonal transport. Trends Neurosci. 12, 474-478.
82. Sims NR, JM Finegan, JP Blass, DM Bowen and D Neary (1987) Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 436, 30-38.
83. Small GW, JC Mazziotta, MT Collins, LR Baxter, ME Phelps, MA Mandelkern, A Kaplan, A La Rue, CF Adamson, L Chang, BH Guze, EH Corder, AM Saunders, JL Haines, MA Pericak-Vance and AD Roses (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273, 942-947.
84. Sokoloff L (1999) Energetics of functional activation in neural tissues. Neurochem. Res. 24, 321-329.
85. Sorensen L, M Ekstrand, JP Silva, E Lindqvist, B Xu, P Rustin, L Olson and NG Larsson (2001) Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J. Neurosci. 21, 8082-8090.
86. Talairach J and P Tournoux (1988) Co-planar stereotaxic atlas of the human brain (Thieme Medical Publishers, Inc.: New York).
87. Tamataini M, K Chandrasekaran and CR Filburn (1987) unpublished observations.
88. Terry RD, E Masliah, DP Salmon, N Butters, R DeTeresa, R Hill, LA Hansen and R Katzman (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
89. VanMeter JW, JM Maisog, TA Zeffiro, M Hallett, P Herscovitch and SI Rapoport (1995) Parametric analysis of functional neuroimages: application to a variable-rate motor task. Neuroimage 2, 272-383.
90. Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283, 1482-1488.
91. Wang SS, A Becerra-Arteaga and TA Good (2002) Development of a novel diffusion-based method to estimate the size of the aggregated Abeta species responsible for neurotoxicity. Biotechnol. Bioeng. 80, 50-59.
92. Wong-Riley MTT (1989) Cytochrome oxidase: An endogenous metabolic marker for neuronal activity. Trends Neurosci. 12, 94-101.
93. Yaffe MP (1999) The machinery of mitochondrial inheritance and behavior. Science 283, 1493-1497.
94. Yao PJ, M Zhu, EI Pyun, AI Brooks, S Therianos, VE Meyers and PD Coleman (2003) Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 12, 97-109.
95. Zhang C and MT Wong-Riley (2000) Synthesis and degradation of cytochrome oxidase subunit mRNAs in neurons: Differential bigenomic regulation by neuronal activity. J. Neurosci. Res. 60, 338-344.